PlasmaMATCH - The UK plasma based molecular profiling of advanced breast cancer to inform therapeuti

PlasmaMATCH is a multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening.

Clinical data and sample collection